592
  Mrv0541 02231214482D          

  6  6  0  0  0  0            999 V2000
    2.3645   -0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3645    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0791    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB00592

> <DRUG_GROUPS>
approved

> <GENERIC_NAME>
Piperazine

> <SYNONYMS>
Piperazidine; Piperazin

> <SALTS>
Piperazine citrate; Piperazine hexahydrate; Piperazine hydrate

> <BRANDS>
Antepar; Uvilon; Vermidol; Vermizine

> <CHEMICAL_FORMULA>
C4H10N2

> <MOLECULAR_WEIGHT>
86.1356

> <EXACT_MASS>
86.08439833

> <IUPAC_NAME>
piperazine

> <IUPAC_TRADITIONAL_NAME>
piperazine

> <INCHI_IDENTIFIER>
InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2

> <INCHI_KEY>
InChIKey=GLUUGHFHXGJENI-UHFFFAOYSA-N

> <SMILES>
C1CNCCN1

> <JCHEM_ACCEPTOR_COUNT>
2

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_BASIC_PKA>
9.56

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <ALOGPS_LOGP>
-1.2

> <JCHEM_LOGP>
-0.73

> <ALOGPS_LOGS>
0.63

> <JCHEM_POLARIZABILITY>
9.97

> <JCHEM_POLAR_SURFACE_AREA>
24.06

> <JCHEM_REFRACTIVITY>
25.45

> <JCHEM_ROTATABLE_BOND_COUNT>
0

> <ALOGPS_SOLUBILITY>
3.71e+02 g/l __ 

$$$$
